Biscayne Neurotherapeutics IPO

Biscayne Neurotherapeutics is a clinical-stage biotechnology company developing novel therapies for difficult-to-treat neurological disorders.

Register for Details

For more details on financing and valuation for Biscayne Neurotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Biscayne Neurotherapeutics

Forge green plus iconForge green minus icon

What is Biscayne Neurotherapeutics funding to date?

Biscayne Neurotherapeutics has raised $9MM to date.
Forge green plus iconForge green minus icon

When was Biscayne Neurotherapeutics founded?

Biscayne Neurotherapeutics was founded in 2017.
Updated on: Jun 12, 2022